To examine the clinical effects of a new bone cement composed of poly(methyl methacrylate)(PMMA)and mineralized collagen(MC)compared with pure PMMA bone cement in treating osteoporotic vertebral compression fractures(...To examine the clinical effects of a new bone cement composed of poly(methyl methacrylate)(PMMA)and mineralized collagen(MC)compared with pure PMMA bone cement in treating osteoporotic vertebral compression fractures(OVCFs)in patients aged over 80.In all,32 cases using pure PMMA bone cement and 31 cases using MC-modified PMMA(MC-PMMA)bone cement for OVCFs between June 2014 and March 2016 were screened as PMMA group and MC-PMMA group,respectively,with an average age of over 80.The operation duration,intraoperative blood loss,hospital stay,oswestry disability index(ODI),visual analogue scale(VAS),anterior vertebral height(AVH),intermediate vertebral height(IVH)and posterior vertebral height(PVH)of injured vertebrae,vertebral computed tomography value,re-fracture rate of adjacent vertebrae,correction rate of spinal kyphotic angle and wedge-shaped vertebra angle and surgical complications were compared between the two groups.In the early post-operative period,the VAS,ODI,AVH and IVH in MC-PMMA group were comparable to those in the traditional PMMA group.Moreover,the MC-PMMA group showed better effects compared with the PMMA group 12months after surgery.Thus,this new bone cement has superior clinic effects in the long term.展开更多
Polymethylmethacrylate(PMMA)bone cement extensively utilized for the treatment of osteoporotic vertebral compression fractures due to its exceptional handleability and mechanical properties.Nevertheless,the clinical a...Polymethylmethacrylate(PMMA)bone cement extensively utilized for the treatment of osteoporotic vertebral compression fractures due to its exceptional handleability and mechanical properties.Nevertheless,the clinical application of PMMA bone cement is restricted by its poor bioactivity and excessively high modulus of elasticity.Herein,mineralized small intestinal submucosa(mSIS)was incorporated into PMMA to prepare a partially degradable bone cement(mSIS-PMMA)that provided suitable compressive strength and reduced elastic modulus compared to pure PMMA.The ability of mSIS-PMMA bone cement to promote the attachment,proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells was shown through cellular experiments carried out in vitro,and an animal osteoporosis model validated its potential to improve osseointegration.Considering these benefits,mSIS-PMMA bone cement shows promising potential as an injectable biomaterial for orthopedic procedures that require bone augmentation.展开更多
基金This work was supported by Natural Science Foundation of Zhejiang Province(LY17H060001)Ningbo Natural Science Foundation(A610225).
文摘To examine the clinical effects of a new bone cement composed of poly(methyl methacrylate)(PMMA)and mineralized collagen(MC)compared with pure PMMA bone cement in treating osteoporotic vertebral compression fractures(OVCFs)in patients aged over 80.In all,32 cases using pure PMMA bone cement and 31 cases using MC-modified PMMA(MC-PMMA)bone cement for OVCFs between June 2014 and March 2016 were screened as PMMA group and MC-PMMA group,respectively,with an average age of over 80.The operation duration,intraoperative blood loss,hospital stay,oswestry disability index(ODI),visual analogue scale(VAS),anterior vertebral height(AVH),intermediate vertebral height(IVH)and posterior vertebral height(PVH)of injured vertebrae,vertebral computed tomography value,re-fracture rate of adjacent vertebrae,correction rate of spinal kyphotic angle and wedge-shaped vertebra angle and surgical complications were compared between the two groups.In the early post-operative period,the VAS,ODI,AVH and IVH in MC-PMMA group were comparable to those in the traditional PMMA group.Moreover,the MC-PMMA group showed better effects compared with the PMMA group 12months after surgery.Thus,this new bone cement has superior clinic effects in the long term.
基金supported by the National Key Research and Development Projects(Grant No.2017YFC1307602)the Scientific Research Projects of PLA(Grant No.145BHQ090003076X)+1 种基金Research Project of PAP(Grant No.CWJ18L004)Logistics College of PAP Projects(Grant No.WHJ201721).
基金supported by Medical Science and Technology Project of Zhejiang Province[2023RC027]the Natural Science Foundation of Ningbo[202003N4281]+1 种基金the Youth Talent Cultivation Program of the Affiliated Hospital of Medical School of Ningbo University[FYQM-LC-202005]GA created with BioRender.com.
文摘Polymethylmethacrylate(PMMA)bone cement extensively utilized for the treatment of osteoporotic vertebral compression fractures due to its exceptional handleability and mechanical properties.Nevertheless,the clinical application of PMMA bone cement is restricted by its poor bioactivity and excessively high modulus of elasticity.Herein,mineralized small intestinal submucosa(mSIS)was incorporated into PMMA to prepare a partially degradable bone cement(mSIS-PMMA)that provided suitable compressive strength and reduced elastic modulus compared to pure PMMA.The ability of mSIS-PMMA bone cement to promote the attachment,proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells was shown through cellular experiments carried out in vitro,and an animal osteoporosis model validated its potential to improve osseointegration.Considering these benefits,mSIS-PMMA bone cement shows promising potential as an injectable biomaterial for orthopedic procedures that require bone augmentation.
